Active ingredientTacalcitolCat. No. P-T002-001CAS 57333-96-7Family · Pharmaceutical analytical standards
Tacalcitol
A synthetic vitamin D3 analogue (1,24-dihydroxyvitamin D3) originating in Japan: applied to the skin as an ointment or lotion, it acts on the vitamin D receptors of keratinocytes and slows their excessive turnover, and is used mainly for psoriasis. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It was the second vitamin D analogue developed as a topical antipsoriatic, and it is on the WHO List of Essential Medicines.
Go to the active ingredient →Active ingredientTacalcitolCat. No. P-T002-001CAS 57333-96-7
Active ingredientTacalcitol monohydrateCat. No. P-T002-002CAS 93129-94-3
Pharmacopoeial impurityTacalcitol EP Impurity ACat. No. P-T002-003CAS 1294517-97-7
ImpurityTacalcitol Impurity 1Cat. No. P-T002-004CAS 57333-95-6No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
ImpurityTacalcitol impurity A CRSEDQM code Y0001824Family TacalcitolReference substanceTacalcitol monohydrate CRSEDQM code Y0001854Family TacalcitolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.